Sucralfate

Levey S , Sheinfeld S. The inhibition of the proteolytic action of pepsin by sulfate containing polysaccharides. Gastroenterology 1954; 27: 625–8.

Anderson W , Walt J. Inhibition of peptic activity protection against histamine ulceration in the guinea pig and combination with gastric mucin by algal polyanion. J Pharm Pharmacol 1959; 11: 318–23.

Walt J , Eagleton GB , Marcus R. The effect of heparin on gastric secretion stimulated by histamine or ametazole hydrochloride. J Pharm Pharmacol 1966; 18: 615–9.

Namekata M , Tanaka T , Sakamoto N , et al . Oliogo-saccharide sulfates and monosaccharide sulfates for medical purposes: III. Antiulcerogenic properties of the sucrose sulfates aluminum complex. Yakugaku Zasshi 1967; 87: 889–93.

Nagashima R , Hirano T. Selective binding of sucralfate to ulcer lesion: I. Experiment in rats with acetic acid-induced gastric ulcer receiving unlabeled sucralfate. Arzneim Forsch 1980; 30: 80–3.

McGraw BF , Hesterlee EJ , Lanza FL , Tesler MA . In-vivo and in-vitro testing of potential antacid properties of sucralfate. Clin Res 1980; 28: 718A.

Nagashima R , Hinohara Y , Hirano T , et al . Selective binding of sucralfate to ulcer lesion: II. Experiments in rats with gastric ulcer receiving “C-sucralfate or potassium ¹⁴C-sucrose sulfate. Arzneim Forsch 1980; 30: 84–8.

Nagashima R , Hinohara Y , Hirano T. Selective binding of sucralfate to ulcer lesion: III. Experiments in rats with duodenal ulcer receiving ¹⁴C-sucralfate. Arzneim Forsch 1980; 30: 88–91.

Bighley LD , Giesing D. Sucralfate. A new concept in ulcer therapy. In: Peptic ulcer disease: an update. New York: Biomedical Information, 1979: 307–20.

Yoshida N , Terao N , Nagashima R. Sucralfate, a basic aluminum salt of sucrose sulfate: IV. Interaction with enzyme pepsin. Arzneim Forsch 1980; 30: 78–80.

Terao N , Yoshida N , Nagashima R. Sucralfate, a basic salt of sucrose sulfate: III. Inhibition of peptic hydrolysis of fibrinogen by sucrose sulfate. Arzneim Forsch 1980; 30: 76–8.

Nagashima R , Yoshida N , Terao N. Sucralfate, a basic aluminum salt of sucrose sulfate: II. Inhibition of peptic hydrolysis as it results from sucrose sulfate interaction with protein substrate, serum albumins. Arzneim Forsch 1980; 30: 73–6.

Borella LE , Seethaler K , Lippman W. Sucralfate: Antipeptic, antiulcer activities and antagonists of gastric emptying. Arzneim Forsch 1979; 29: 793–8.

Nagazawa S , Nagashima R , Samloff IM . Selective binding of sucralfate to gastric ulcer in man. Dig Dis Sci 1981; 26: 297–300.

Masuda M , Taniguchi M , Takafuji H , Ulda M , Suzuki S , Morino T. Clinical effect of ulcermin on peptic ulcer. Shinyro (Diagnosis and Therapy) 1970; 23: 93–8.

Caspary WF . Effect of sucralfate on in vitro binding of bile acids and on bile acid-induced changes of transmural potential difference in healthy subjects. Hepato-Gastroenterol 1980; 27(June suppl): 382.

Shimizu M , Ishii A , Imai T , et al . Experimental studies on antiulcerous activity of basic aluminum sucrose sulfate (CG-A6J): I. Assessment of CG-A6J for antiulcerous, antacid, and antipepsin activities in pylorus-ligated rats and effect of CG-A6J on blood coagulability in rabbit. Kiso-to-Rinsho (Clinical Report) 1968; 2: 374–82.

Namekata M , Yamazaki T , Momose A , et al . Pharmacologic studies on basic aluminum sucrose sulfate. Data on file, Marion Laboratories, Kansas City, MO.

Shimizu M , Shibuya E , Ishii A , et al . Experimental studies on antiulcerous activity of basic aluminum sucrose sulfate (CG-A6J): III. Effects on clamping cortisone ulcers. Kiso-to-Rinsho (Clinical Report) 1968; 2: 383–93.

Kakimoto M , Suzano S , Suzuki S. The effects of sucralfate on gastrointestinal peristalsis. Data on file, Marion Laboratories, Kansas City, MO, 1975.

Hirano T , Yokota K , Takagaki Y. Effect of basic aluminum sucrose sulfate (Ulcermin) on gastric emptying in the rat. Data on file, Marion Laboratories, Kansas City, MO, 1975.

Suzuki S , Kamiyama H , Suzuki H , et al . Basic aluminum sucrose sulfate: its absorption, distribution, and excretion in rats. Data on file, Marion Laboratories, Kansas City, MO, 1976.

Matsuo Y , Seki A. Effects on experimental ulcers and the autolyzing phenomenon of the gastric mucosa. Data on file, Marion Laboratories, Kansas City, MO.

Hirano T , Takagaki Y. Healing promotion effects of sucrose sulfate aluminum ester (Ulcermin) on acetic acid induced ulcer. Kiso-to-Rinsho (Clinical Report) 1974; 8(4): 1–12.

Miyoshi A , Moriga M , Kobayashi M , Suyama T , Kiguchi Y , Kishimoto S. Experimental and clinical studies on anti-pepsin preparations: I. Anti-pepsin and anti-ulcerogenic activities of sucrose sulfate. Jap Arch Intern Med 1968; 15: 419–34.

Shimizu M , Shibuya E , Ishii A , et al . Experimental studies of an antiulcerous activity of basic aluminum sucrose sulfate (CG-A6J): II. Effects of CG-A6J on histamine and stress ulcerations. Kiso-to-Rinsho (Clinical Report) 1968; 2: 374–82.

Eberstein MV . Acute toxicity study in rabbits after oral administration. Data on file, Marion Laboratories, Kansas City, MO, 1975.

Hirano T , Fukaya T , Yokoyama N , Niki R , Ohtani T. Toxicity studies of basic aluminum sucrose sulfate. Acute, subacute, and chronic. Data on file, Marion Laboratories, Kansas City, MO, 1966.

McHardy GC . Role of sucralfate in duodenal ulcer disease. In: Peptic ulcer disease: an update. New York: Biomedical Information, 1979: 321–32.

Moshal MG , Spitaels JM , Khan F. Sucralfate in the treatment of duodenal ulcers: a double-blind, endoscopically controlled trial. S Afr Med J 1980; 57: 742–8.

Ishimori A. A multi-center, double-blind, placebo-controlled study of sucralfate in the treatment of peptic ulcer in Japan. Hepato-Gastroenterol 1980; 27(June suppl): 384.

Elliot C , Orchard R. A double-blind, placebo-controlled study of sucralfate in the treatment of gastric and duodenal ulcer. Hepato-Gastroenterol 1980; 27(June suppl): 384.

May berry JF , Rhodes J , Williams R. A controlled clinical trial of sucralfate in the treatment of gastric ulcer. Hepato-Gastroenterol 1980; 27(June suppl): 384.

Marks IN , Lucky W , Wright JP . Comparison of sucralfate with cimetidine in short-term treatment of chronic peptic ulcers. S Afr Med J 1980; 57: 567–73.

Miyake T. Endoscopic evaluation of the effect of sucralfate therapy and other clinical parameters on the recurrence rate of gastric ulcers. Dig Dis Sci 1980; 25: 1–7.

Pentaloza-Rosas A. Sucralfate in the treatment of gastric ulcer, antacid-controlled clinical trial. Hepato-Gastroenterol 1980; 27(June suppl): 385.

Yamagata S , Ishimori A. Clinical evaluation of pharmacotherapy for peptic ulcer with antipepsin agents by double-blind technique-multicenter clinical study. Tohoku J Exp Med 1973; 110: 377–404.

Nakazawa S , Odoii Y , Mizuno F , Naito Y. Clinical efficacy of a placenta extract preparation, PLP injection in gastric ulcer-comparative study with basic aluminum sucrose sulfate by double-blind technique. Rinsho Hyoka (Clinical Evaluation) 1973; 1: 139–43.

Shimizu M , Ishii A , Yoshikawa H , et al . Treatment of peptic ulcer with ulcermin. Rinsho to Kenkyu 1970; 47: 207–15.

Data on file, Marion Laboratories, Kansas City, MO, 1980.